Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA 2023-03-02 14:09
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting 2023-03-01 19:00
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference 2023-02-28 21:00
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology 2023-02-28 08:53
Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology 2023-02-28 01:00
Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023 2023-02-27 21:00
Singleron Biotechnologies and Macrogen Europe announce a strategic alliance 2023-02-27 16:00
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform 2023-02-24 20:00
Dr. Lilly Xu Named President of Shanghai ChemPartner 2023-02-24 05:53
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 2023-02-23 13:01
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration 2023-02-22 22:00
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate 2023-02-22 21:00
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study 2023-02-22 20:30
Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA 2023-02-22 20:17
Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON 2023-02-21 21:30
NMPA accepted the registration applications for Uro-G and Uro-3500 2023-02-21 17:46
1 59 60 61 62 63 222